STING CDN agonist IFM Therapeutics
Modify Date: 2024-01-04 19:26:07
STING CDN agonist IFM Therapeutics structure
|
Common Name | STING CDN agonist IFM Therapeutics | ||
|---|---|---|---|---|
| CAS Number | 2197188-04-6 | Molecular Weight | 582.542 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H26N14O6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of STING CDN agonist IFM TherapeuticsSTING CDN agonist IFM Therapeutics is a synthetic cyclic dinucleotide (CDN) agonist of STING, stimulates potent immunity against cancer. |
| Name | STING CDN agonist IFM Therapeutics |
|---|
| Description | STING CDN agonist IFM Therapeutics is a synthetic cyclic dinucleotide (CDN) agonist of STING, stimulates potent immunity against cancer. |
|---|---|
| References | References 1. Patent WO 2018045204. View Related Products by Target STING |
| Molecular Formula | C22H26N14O6 |
|---|---|
| Molecular Weight | 582.542 |